AEST.MED.INT.HLD.SP.ADR/3 Net Asset Quality Index
AEST.MED.INT.HLD.SP.ADR/3 net asset quality index. AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Net Asset Quality Index of -8.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €510.89 Million minus total liabilities of €554.12 Million yields net assets of €-43.23 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore AEST.MED.INT.HLD.SP.ADR/3 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
Net asset quality index of AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025. This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at -8.5%, representing net assets of €-43.23 Million against total assets of €510.89 Million EUR. See AEST.MED.INT.HLD.SP.ADR/3 book value and equity for net asset value and shareholders' equity analysis.
AEST.MED.INT.HLD.SP.ADR/3 Net Asset Quality Index by Year (2021–2025)
AEST.MED.INT.HLD.SP.ADR/3 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 3FMA company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -8.5% | €-43.23 Million | €510.89 Million | €554.12 Million | ▼ -10.4 pp |
| 2024 | 1.9% | €9.35 Million | €486.22 Million | €476.88 Million | ▼ -4.1 pp |
| 2023 | 6.0% | €33.63 Million | €560.66 Million | €527.03 Million | ▲ +29.0 pp |
| 2022 | -23.0% | €-125.88 Million | €546.37 Million | €672.25 Million | ▲ +9.3 pp |
| 2021 | -32.3% | €-186.42 Million | €576.94 Million | €763.36 Million | — |